[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 318 Agreed to Senate (ATS)]

<DOC>






116th CONGRESS
  1st Session
S. RES. 318

To support the Global Fund to fight AIDS, Tuberculosis and Malaria, and 
                        the Sixth Replenishment.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           September 18, 2019

   Mr. Risch (for himself, Mr. Menendez, Mr. Isakson, Mr. Coons, Mr. 
Rubio, Mr. Cardin, Mr. Markey, Mr. Sullivan, Ms. Cantwell, Mrs. Capito, 
  Mr. Manchin, Mr. Cruz, Mr. Young, Mr. Blumenthal, Ms. Collins, Mr. 
Boozman, Mr. Wyden, Mr. Wicker, Ms. Rosen, Mrs. Murray, and Mr. Peters) 
submitted the following resolution; which was referred to the Committee 
                          on Foreign Relations

                           September 26, 2019

                 Reported by Mr. Risch, with amendments

                            December 2, 2019

                   Considered, amended, and agreed to

_______________________________________________________________________

                               RESOLUTION


 
To support the Global Fund to fight AIDS, Tuberculosis and Malaria, and 
                        the Sixth Replenishment.

Whereas the Global Fund to Fight AIDS, Tuberculosis, and Malaria has been an 
        effective partnership of governments, the private sector, civil society, 
        and affected communities to galvanize political and financial efforts to 
        improve the response to these epidemics since 2002;
Whereas, in 2017, the Global Fund contributed to extraordinary improvements in 
        global health that would otherwise not have occurred, including a more 
        than 50 percent reduction in the number of AIDS-related deaths since the 
        peak in 2005, a 37 percent decline in tuberculosis (TB) deaths since 
        2000, and a 60 percent decline in the number of malaria deaths since 
        2000;
Whereas, since the Global Fund's creation in 2002, more than 27,000,000 lives 
        have been saved in the countries where it invests;
Whereas the Global Fund and its partners work to maintain a steadfast commitment 
        to transparency and accountability and have received high marks in 
        multilateral aid reviews and by independent watchdog groups;
Whereas a 2019 study published in the Annals of Global Health found evidence of 
        associated improvements in government accountability, control of 
        corruption, political freedoms, regulatory quality, and rule of law that 
        are significant in countries where the Global Fund invests;
Whereas, despite progress in combating AIDS, tuberculosis, and malaria, 
        challenges such as drug and insecticide resistance, reaching 
        marginalized and vulnerable populations, and complacency in the fight 
        against infectious diseases threaten further progress;
Whereas United States leadership has been critical to the success of the Global 
        Fund, both as its largest donor and through its oversight role on the 
        Board of the Global Fund;
Whereas Global Fund programs and activities support and complement United States 
        bilateral health programs, including the President's Emergency Plan for 
        AIDS Relief, the President's Malaria Initiative, and the United States 
        Agency for International Development tuberculosis program;
Whereas the United States is limited by law from contributing more than 33 
        percent of the Global Fund budget, thereby encouraging other partners to 
        significantly increase their contributions;
Whereas the Global Fund's requirements for co-financing have spurred domestic 
        investments, with recipient countries committing 41 percent more of 
        their own funding to fight AIDS, tuberculosis, and malaria for 2018-2020 
        compared to 2015-2017;
Whereas the Global Fund has called on donors to support its Sixth Replenishment 
        by mobilizing a minimum of $14,000,000,000 in donor commitments for 
        2021-2023;
Whereas Canada, the European Union, Germany, India, Ireland, Italy, Luxembourg, 
        Japan, Portugal, Switzerland, and the United Kingdom have responded to 
        the call by significantly increasing their respective pledges for the 
        Sixth Replenishment;
Whereas recipient countries also are expected to increase their co-financing by 
        48 percent, growing to $46,000,000,000 in 2021-2023; and
Whereas, with these resources secured, the Global Fund projects it will reduce 
        the number of deaths due to AIDS, TB, and malaria by nearly 50 percent, 
        avert 234,000,000 infections or disease cases, and save an additional 
        16,000,000 lives: Now, therefore, be it
    Resolved, That the Senate--
            (1) commends the work of the Global Fund and its partners 
        for their contributions aimed at ending the epidemics of AIDS, 
        tuberculosis, and malaria;
            (2) affirms the support of the United States for the goal 
        of securing a minimum of $14,000,000,000 in donor commitments 
        for the Sixth Global Fund Replenishment, to be held on October 
        10, 2019, in Lyon, France;
            (3) supports United States contributions of 33 percent of 
        the budget provided by the Global Fund's Sixth Replenishment, 
        consistent with section 202(d) of the United States Leadership 
        Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22 
        U.S.C. 7622(d)), and provided that the Fund continues to uphold 
        its longstanding commitment to transparency, accountability, 
        and results in combating AIDS, tuberculosis, and malaria;
            (3) (4) urges donor countries to step up the fight and 
        increase their pledges for the Sixth Global Fund Replenishment;
            (4) (5) urges Global Fund recipient countries to continue 
        to make and meet ambitious co-financing commitments to sustain 
        progress in ending the epidemics of AIDS, tuberculosis, and 
        malaria; and
            (5) (6) encourages United States bilateral aid programs to 
        continue their collaboration with the Global Fund to maximize 
        the life-saving impact of global health investments.
                                 <all>